Follow
Yumeng Yang
Yumeng Yang
McWilliams School of Biomedical Informatics, University of Texas Health Science Center
Verified email at uth.tmc.edu
Title
Cited by
Cited by
Year
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research
AD Sherry, KL Corrigan, R Kouzy, JA Jaoude, Y Yang, RR Patel, ...
Cancer 129 (21), 3430-3438, 2023
42023
Text Classification of Cancer Clinical Trial Eligibility Criteria
Y Yang, S Jayaraj, E Ludmir, K Roberts
AMIA Annual Symposium Proceedings 2023, 1304, 2023
12023
Exploring the Generalization of Cancer Clinical Trial Eligibility Classifiers Across Diseases
Y Yang, A Gilliam, EB Ludmir, K Roberts
arXiv preprint arXiv:2403.17135, 2024
2024
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
EJ Hsu, TA Lin, DR Dabush, Z McCaw, A Koong, C Lin, J Abi Jaoude, ...
JNCI: Journal of the National Cancer Institute, djae028, 2024
2024
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
AD Sherry, P Msaouel, ZR McCaw, J Abi Jaoude, EJ Hsu, R Kouzy, ...
European Journal of Cancer 194, 113357, 2023
2023
Causal Models, Prediction, and Extrapolation in Cell Line Perturbation Experiments
JP Long, Y Yang, KA Do
arXiv preprint arXiv:2207.09991, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6